These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 1868454)
1. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. Griffin T; Raso V Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of antitumor immunotoxins by liposomal monensin. Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373 [TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147 [TBL] [Abstract][Full Text] [Related]
5. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain. Trown PW; Reardan DT; Carroll SF; Stoudemire JB; Kawahata RT Cancer Res; 1991 Aug; 51(16):4219-25. PubMed ID: 1868442 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores. Griffin TW; Childs LR; FitzGerald DJ; Levin LV J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice. Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069 [TBL] [Abstract][Full Text] [Related]
8. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment. Colombatti M; Dell'Arciprete L; Chignola R; Tridente G Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092 [TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
11. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro. Recht LD; Griffin TW; Raso V; Salimi AR Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397 [TBL] [Abstract][Full Text] [Related]
13. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer. Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin. Griffin TW; Pagnini PG; Houston LL J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277 [TBL] [Abstract][Full Text] [Related]
16. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates. Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050 [TBL] [Abstract][Full Text] [Related]
17. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. Ramakrishnan S; Bjorn MJ; Houston LL Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383 [TBL] [Abstract][Full Text] [Related]
18. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins. Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079 [TBL] [Abstract][Full Text] [Related]
19. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin. Yokota S; Hara H; Luo Y; Seon BK Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557 [TBL] [Abstract][Full Text] [Related]
20. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]